BioNTech SE (BNTX) Total Non-Current Liabilities (2018 - 2026)

BioNTech SE has reported Total Non-Current Liabilities for 8 years, with the latest figure at $724.2 million in Q4 2025.

• Quarterly Total Non-Current Liabilities rose 13.82% year-over-year to $724.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $724.2 million (up 13.82% YoY) and the FY2025 annual result came in at $702.9 million, up 10.47% from the prior year.
• Total Non-Current Liabilities retreated to $724.2 million in Q4 2025 per BNTX's latest filing, from $749.7 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $1.5 billion in Q2 2025 and troughed at $278.4 million in Q4 2022.
• A 5-year average of $639.9 million and a median of $620.8 million in 2021 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2021 and 2022: Total Non-Current Liabilities jumped 237.3% in 2021, then tumbled 53.47% in 2022.
• Over 5 years, Total Non-Current Liabilities stood at $521.1 million in 2021, then slumped by 46.57% to $278.4 million in 2022, then jumped by 166.6% to $742.3 million in 2023, then declined by 14.29% to $636.2 million in 2024, then rose by 13.82% to $724.2 million in 2025.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $724.2 million, $749.7 million, and $1.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.